36 related articles for article (PubMed ID: 28792693)
1. GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease.
Farag NM; Mousa M; Elsayed E; Ismeil A
Ital J Pediatr; 2023 Aug; 49(1):106. PubMed ID: 37649102
[TBL] [Abstract][Full Text] [Related]
2. Iron in multiple myeloma.
VanderWall K; Daniels-Wells TR; Penichet M; Lichtenstein A
Crit Rev Oncog; 2013; 18(5):449-61. PubMed ID: 23879589
[TBL] [Abstract][Full Text] [Related]
3. Isolated ACTH deficiency: an uncommon cause of hyperferritinaemia.
Isoda A; Saito A; Matsumoto M; Sawamura M
BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37816574
[TBL] [Abstract][Full Text] [Related]
4. Retreatment and prolonged therapy with subcutaneous bortezomib in patients with relapsed multiple myeloma: A randomized, controlled, phase III study.
Terpos E; Gobbi M; Potamianou A; Lahaye M; Couturier C; Cavo M
Eur J Haematol; 2018 Jan; 100(1):10-19. PubMed ID: 28801967
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials.
Lakshman A; Abeykoon JP; Kumar SK; Rajkumar SV; Dingli D; Buadi FK; Gonsalves WI; Leung N; Dispenzieri A; Kourelis TV; Go RS; Lacy MQ; Hobbs MA; Lin Y; Warsame R; Lust J; Fonder AL; Hwa YL; Hayman SR; Russell SJ; Kyle RA; Gertz MA; Kapoor P
Am J Hematol; 2017 Nov; 92(11):1146-1155. PubMed ID: 28799231
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of multiple myeloma among patients in successive lines of therapy in the United States.
MacEwan JP; Batt K; Yin W; Peneva D; Sison S; Vine S; Chen C
Leuk Lymphoma; 2018 Apr; 59(4):941-949. PubMed ID: 28805105
[TBL] [Abstract][Full Text] [Related]
7. Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses.
Gupta N; Yang H; Hanley MJ; Zhang S; Liu R; Kumar S; Richardson PG; Skacel T; Venkatakrishnan K
Target Oncol; 2017 Oct; 12(5):643-654. PubMed ID: 28803351
[TBL] [Abstract][Full Text] [Related]
8. Gender-Specific Aspects in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: A Single-Center Experience.
Posch D; Rabitsch W; Wohlfarth P; Leiner M; Porpaczy E; Drach J; Raderer M; Lamm W
Oncology; 2017; 93(5):295-301. PubMed ID: 28803241
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma with extramedullary disease: impact of autologous stem cell transplantation on outcome.
Kumar L; Gogi R; Patel AK; Mookerjee A; Sahoo RK; Malik PS; Sharma A; Thulkar S; Kumar R; Biswas A; Sharma OD; Gupta R
Bone Marrow Transplant; 2017 Oct; 52(10):1473-1475. PubMed ID: 28805789
[No Abstract] [Full Text] [Related]
10. Pleural Effusion in Multiple Myeloma: Characteristics and Practice Patterns.
Byun JM; Kim KH; Choi IS; Park JH; Kim JS; Shin DY; Koh Y; Kim I; Yoon SS; Lim HJ
Acta Haematol; 2017; 138(2):69-76. PubMed ID: 28797003
[TBL] [Abstract][Full Text] [Related]
11. Serum Interleukin-9 Concentration Is Associated with the Hemoglobin Level and Renal Function in Patients with Multiple Myeloma.
Chang Y; Xing X; Jiang Y; Shi X; Xu Y; Li A; Feng X; Zhang Y; Kong D; Zheng C
Ann Clin Lab Sci; 2019 Sep; 49(4):513-518. PubMed ID: 31471342
[TBL] [Abstract][Full Text] [Related]
12. Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient Outcome.
Plano F; Gigliotta E; Corsale AM; Azgomi MS; Santonocito C; Ingrascì M; Di Carlo L; Augello AE; Speciale M; Vullo C; Rotolo C; Camarda GM; Caccamo N; Meraviglia S; Dieli F; Siragusa S; Botta C
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240197
[TBL] [Abstract][Full Text] [Related]
13. Calculated Whole Blood Viscosity and Albumin/Fibrinogen Ratio in Patients with a New Diagnosis of Multiple Myeloma: Relationships with Some Prognostic Predictors.
Carlisi M; Lo Presti R; Mancuso S; Siragusa S; Caimi G
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979941
[TBL] [Abstract][Full Text] [Related]
14. Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance.
Wang G; Ning FY; Wang JH; Yan HM; Kong HW; Zhang YT; Shen Q
World J Clin Cases; 2019 Dec; 7(24):4234-4244. PubMed ID: 31911904
[TBL] [Abstract][Full Text] [Related]
15. New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia.
Banaszkiewicz M; Małyszko J; Vesole DH; Woziwodzka K; Jurczyszyn A; Żórawski M; Krzanowski M; Małyszko J; Batko K; Kuźniewski M; Krzanowska K
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31683939
[TBL] [Abstract][Full Text] [Related]
16. Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions.
Dignass A; Farrag K; Stein J
Int J Chronic Dis; 2018; 2018():9394060. PubMed ID: 29744352
[TBL] [Abstract][Full Text] [Related]
17. Serum Hepcidin Levels in Multiple Myeloma.
Victor M; Evgeniy H; Gergana T; Julia P; Vasil V; Borislav M; Ivo B; Zlatina G; Kamen T
Clin Lab; 2017 Jul; 63(7):1273-1277. PubMed ID: 28792693
[TBL] [Abstract][Full Text] [Related]
18. Dilemma: Correlation Between Serum Level of Hepcidin and IL-6 in Anemic Myeloma Patients.
Ibricevic-Balic L; Icindic-Nakas E; Hasic S; Kiseljakovic E; Sofo-Hafizovic A; Balic S
Med Arch; 2016 Dec; 70(6):429-432. PubMed ID: 28210014
[TBL] [Abstract][Full Text] [Related]
19. [Peripheral blood monocyte hepcidin in patients with multiple myeloma is associated with anemia of chronic disease].
Han X; Zhou DB; Duan MH; Wang X; Zhang JP; Zhao YQ; Shen T; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):403-9. PubMed ID: 23628042
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
